(NASDAQ:OCUL) a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye today announced top line results for a Phase 2 clinical trial evaluating Sustained Release Dexamethasone (OTX-DP) for treatment of allergic conju
conjunctivitis与发音含义,同义词,反义词,翻译,刑和更多的